Loading...
XIDX
MRAT
Market cap9mUSD
Nov 12, Last price  
380.00IDR
Name

Mustika Ratu Tbk PT

Chart & Performance

D1W1MN
XIDX:MRAT chart
P/E
P/S
0.49
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
1.79%
Revenues
333.56b
+10.97%
307,804,260,789345,575,853,364369,366,074,883406,315,784,681458,197,338,824358,127,545,503434,747,101,600428,092,732,505344,361,345,265344,678,666,245300,572,751,733305,224,577,860318,408,499,475326,794,571,097285,177,566,612300,596,022,300333,562,950,000
Net income
-5.12b
L-63.77%
22,290,067,70721,016,846,72024,418,796,93027,867,834,53230,751,407,882-6,700,373,0767,054,710,4111,045,990,311-5,549,465,678-1,319,951,850-2,257,132,420131,182,389-6,766,719,891358,126,93167,833,011,050-14,140,399,378-5,122,539,000
CFO
5.30b
P
000012,708,802,3428,221,522,955-22,679,473,943-8,272,888,090-16,529,433,188-10,355,155,394-5,750,378,923-6,529,917,745-18,174,189,911-6,645,903,88567,833,011,050-26,387,483,2245,301,482,000
Dividend
Jul 11, 201316.525 IDR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PT Mustika Ratu Tbk, together with its subsidiaries, engages in the manufacture, trading, and distribution of herbal and traditional cosmetics, body care products, jamu, health drinks, ready to drink products, and other related products in Indonesia. Its products include Herbamuno+ herbal supplements, face washes, moisturizers, tone up body serums, 2 in 1 cleanser and toners, face mask creams, and powder masks. The company was founded in 1978 and is headquartered in Jakarta, Indonesia. PT Mustika Ratu Tbk is a subsidiary of PT Mustika Ratu Investama.
IPO date
Jul 27, 1995
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT